Personalized Medicine and Pharmacogenomics

EasyChair Preprint 15039

Abstract

Personalized medicine represents a paradigm shift in healthcare, focusing on tailoring medical treatment to individual characteristics, such as genetics, lifestyle, and environment. Pharmacogenomics, a key component of personalized medicine, explores how genetic variations influence drug response. This field enables the development of precise medical therapies, reducing adverse drug reactions and optimizing drug efficacy. By integrating genetic data into clinical decision-making, pharmacogenomics allows for customized treatment plans that enhance patient outcomes. Despite significant progress, challenges remain in the implementation of personalized medicine, including ethical concerns, high costs, and the need for widespread genetic literacy among healthcare providers. Continued research and advancements in genomic technologies will be critical in overcoming these obstacles and fully realizing the potential of personalized medicine.

Keyphrases: Aurora kinase, BET, Bromodomain, CDK, CDK9, Epigenetics, cancer, computer-aided drug design, dual inhibitor, inhibitor, kinase

@booklet{EasyChair:15039,
  author    = {Favour Olaoye and Kaledio Potter and Axel Egon},
  title     = {Personalized Medicine and Pharmacogenomics},
  howpublished = {EasyChair Preprint 15039},
  year      = {EasyChair, 2024}}